Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03673839
Other study ID # NU382
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 20, 2018
Est. completion date November 21, 2018

Study information

Verified date November 2018
Source Danone Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study purpose is to assess various protein blends, which differ in protein quality, and the impact on blood amino acid response in male subjects.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date November 21, 2018
Est. primary completion date November 21, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Healthy, resistance-trained adult men 18-35 years of age, inclusive, at the screening visit.

- BMI between 18.5 and 29.9 kg/m² inclusive at sceening

- Self-reported resistance training experience of no less than two years , and have participated in resistance training of at least 1h two days per week for the past six months.

- Willing to abstain from any protein supplements for 1 day prior to the study intervention phase (i.e. from the randomised visit, Visit 2)

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Animal Proteins (crossover)
Animal proteins mixed with water and consumed as a beverage once by the subject in a 4x4 Williams square crossover design
Plant-based protein blends type 1 (crossover)
Plant-based protein blends mixed with water and consumed as a beverage once by the subject in a 4x4 Williams square crossover design
Plant-based protein blends type 2 (crossover)
Plant-based protein blends mixed with water and consumed as a beverage once by the subject in a 4x4 Williams square crossover design
Plant-based protein blends type 3 (crossover)
Plant-based protein blends mixed with water and consumed as a beverage once by the subject in a 4x4 Williams square crossover design

Locations

Country Name City State
Canada Glycemic, Index Laboratories, Inc. Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
Danone North America

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Time to reach the maximum amount of plasma branch chain amino acid amounts The time to reach the maximum of plasma branch chain amino acid amount will be measured over 4 hours 4 hours
Primary Plasma essential amino acids amounts Following an overnight fast, blood amino acids will be measured over 4 hours 4 hours
Secondary Kinetic response of the branch chain amino acids Following an overnight fast, plasma branch chain amino acids amounts (area under the curve) will be measured over 4 hours at fasting 4 hours
Secondary Maximum amount of plasma branch chain amino acid amounts The maximum plasma branch chain amino acid amount will be measured over 4 hours 4 hours